» Articles » PMID: 31133850

Nanofibrous Scaffolds Support a 3D Permeability Model of the Human Intestinal Epithelium

Overview
Journal Front Pharmacol
Date 2019 May 29
PMID 31133850
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Advances in drug research not only depend on high throughput screening to evaluate large numbers of lead compounds but also on the development of models which can simulate human tissues in terms of drug permeability and functions. Potential failures, such as poor permeability or interaction with efflux drug transporters, can be identified in epithelial Caco-2 monolayer models and can impact a drug candidate's progression onto the next stages of the drug development process. Whilst monolayer models demonstrate reasonably good prediction of permeability for some compounds, more developed tools are needed to assess new entities that enable closer correlation. In this study, an model of the human intestinal epithelium was developed by utilizing nanofibers, fabricated using electrospinning, to mimic the structure of the basement membrane. We assessed Caco-2 cell response to these materials and investigated the physiological properties of these cells cultured on the fibrous supports, focusing on barrier integrity and drug-permeability properties. The obtained data illustrate that 2D Caco-2 Transwell cultures exhibit artificially high trans-epithelial electrical resistance (TEER) compared to cells cultured on the 3D nanofibrous scaffolds which show TEER values similar to porcine tissue (also measured in this study). Furthermore, our results demonstrate that the 3D nanofibrous scaffolds influence the barrier integrity of the Caco-2 monolayer to confer drug-absorption properties that more closely mimic native gut tissue particularly for studying passive epithelial transport. We propose that this 3D model is a suitable model for investigating drug absorption and intestinal metabolism.

Citing Articles

Bioengineering the Human Intestinal Mucosa and the Importance of Stromal Support for Pharmacological Evaluation In Vitro.

Freer M, Cooper J, Goncalves K, Przyborski S Cells. 2024; 13(22).

PMID: 39594608 PMC: 11592477. DOI: 10.3390/cells13221859.


Ultra-thin and ultra-porous nanofiber networks as a basement-membrane mimic.

Graybill P, Jacobs 4th E, Jana A, Agashe A, Nain A, Davalos R Lab Chip. 2023; 23(20):4565-4578.

PMID: 37772328 PMC: 10623910. DOI: 10.1039/d3lc00304c.


Biofabrication methods for reconstructing extracellular matrix mimetics.

Aazmi A, Zhang D, Mazzaglia C, Yu M, Wang Z, Yang H Bioact Mater. 2023; 31:475-496.

PMID: 37719085 PMC: 10500422. DOI: 10.1016/j.bioactmat.2023.08.018.


Three-Dimensional Scaffolds for Bone Tissue Engineering.

Chinnasami H, Dey M, Devireddy R Bioengineering (Basel). 2023; 10(7).

PMID: 37508786 PMC: 10376773. DOI: 10.3390/bioengineering10070759.


Vascularizing the brain .

Aazmi A, Zhou H, Lv W, Yu M, Xu X, Yang H iScience. 2022; 25(4):104110.

PMID: 35378862 PMC: 8976127. DOI: 10.1016/j.isci.2022.104110.


References
1.
Moeser A, Klok C, Ryan K, Wooten J, Little D, Cook V . Stress signaling pathways activated by weaning mediate intestinal dysfunction in the pig. Am J Physiol Gastrointest Liver Physiol. 2006; 292(1):G173-81. DOI: 10.1152/ajpgi.00197.2006. View

2.
Artursson P, Karlsson J . Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991; 175(3):880-5. DOI: 10.1016/0006-291x(91)91647-u. View

3.
Volpe D . Application of method suitability for drug permeability classification. AAPS J. 2010; 12(4):670-8. PMC: 2976984. DOI: 10.1208/s12248-010-9227-8. View

4.
Balimane P, Chong S . Cell culture-based models for intestinal permeability: a critique. Drug Discov Today. 2005; 10(5):335-43. DOI: 10.1016/S1359-6446(04)03354-9. View

5.
Westerhout J, van de Steeg E, Grossouw D, Zeijdner E, Krul C, Verwei M . A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. Eur J Pharm Sci. 2014; 63:167-77. DOI: 10.1016/j.ejps.2014.07.003. View